bluebird bio Files Q1 2025 10-Q
| Field | Detail |
|---|---|
| Company | Bluebird Bio, Inc. |
| Form Type | 10-Q |
| Filed Date | May 14, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotechnology, financial-reporting
TL;DR
bluebird bio filed its Q1 2025 10-Q. Check financials.
AI Summary
bluebird bio, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Genetix Pharmaceuticals Inc., is based in Somerville, MA. This filing provides an update on its financial position and business operations for the first quarter of 2025.
Why It Matters
This filing provides investors with the latest financial and operational details for bluebird bio, Inc. as of March 31, 2025, crucial for understanding the company's performance and outlook.
Risk Assessment
Risk Level: medium — As a biotechnology company, bluebird bio operates in a high-risk, high-reward industry with significant regulatory and market uncertainties.
Key Players & Entities
- bluebird bio, Inc. (company) — Filer of the 10-Q report
- Genetix Pharmaceuticals Inc. (company) — Former name of bluebird bio, Inc.
- Somerville, MA (location) — Location of bluebird bio, Inc. headquarters
- 20250331 (date) — End of the reporting period
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended March 31, 2025.
What is the company's ticker symbol?
The ticker symbol is not explicitly mentioned in the provided text, but the filing is for bluebird bio, Inc.
Where is bluebird bio, Inc. headquartered?
bluebird bio, Inc. is headquartered at 455 Grand Union Boulevard, Somerville, MA 02145.
When was the company formerly known as?
The company was formerly known as Genetix Pharmaceuticals Inc., with a date of name change on June 16, 2004.
What is the SEC file number for this company?
The SEC file number for bluebird bio, Inc. is 001-35966.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding bluebird bio, Inc..